1608482-07-0

Upstream product

• 1409950-72-6 tert-butyl ((2R,6S,7R,13aS,14aR,16aS,Z)-2-hydroxy-7,9-dimethyl-14a-(((1-methylcyclopropyl)sulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl)carbamate 
• 1409950-74-8 tert-butyl ((2S,3R)-1-((2S,4R)-4-hydroxy-2-(((1R,2S)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,5-dimethyl-1-oxonon-8-en-2-yl)carbamate 
• 1608483-06-2 (1R,2S)-1-amino-N-((1-methylcyclopropyl)sulfonyl)-2-vinylcyclopropanecarboxamide trifluoroacetic acid 
• 1409950-73-7 (2S,4R)-1-((2S,3R)-2-((tert-butoxycarbonyl)amino)-3,5,-dimethylnon-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid 
• 1407254-33-4 (3R)-2-((tert-butoxycarbonyl)amino)-3,5-dimethylnon-8-enoic acid 
• 40216-83-9 L-4-hydroxyproline methyl ester hydrochloride 
• 1608482-73-0 2,4-dichloro-6-(4-isopropoxyphenyl)pyridine 
• 1409950-70-4 (2S,4R)-methyl 1-((2S,3R)-2-((tert-butoxycarbonyl)amino)-3,5-dimethylnon-8-enoyl)-4-hydroxypyrrolidine-2-carboxylate 
• 153624-46-5 4-(isopropoxy)phenylboronic acid 
• 16063-69-7 2,4,6-trichloropyridine 
• 1608482-76-3 2-(4-chloro-6-(4-isopropoxyphenyl)pyridin-2-yl)pyrazine 
• 630424-75-8 pyridin-2-yl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate 
• 1608483-23-3 (2R,6S,7R,13aS,14aR,16aS,Z)-6-amino-2-((2-(4-isopropoxyphenyl)-6-(pyrazin-2-yl)pyridin-4-yl)oxy)-7,9-dimethyl-N-((1-methylcyclopropyl)sulfonyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide trifluoroacetic acid salt 

Relevant academic research and scientific papers

HEPATITIS C VIRUS INHIBITORS

Hepatitis C virus inhibitors having the general formula (I) [PLEASE INSERT CHEMICAL STRUCTURE HERE], are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.